Norway
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -1.90 M
|
Dec. 31, 2023 | USD 0.23 | -0.24% |
|
Norway |
|
2 |
USD -1.21 M
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
3 |
USD -440.51 K
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
4 |
USD -1.49 K
|
Dec. 31, 2024 | USD 0.19 | -0.80% |
|
Norway |
|
5 |
USD 0.00
|
Dec. 31, 2023 | USD 0.73 | 3.02% |
|
Norway |
The Vaccines company in Norway with the highest Capital Expenditure is Nykode Therapeutics AS (Oslo Stock Exchange: NYKD.OL) at USD -1.90 M.
The Vaccines company in Norway with the lowest Capital Expenditure is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at USD 0.00.
The top 10 Vaccines companies in Norway by Capital Expenditure are Nykode Therapeutics AS, Photocure ASA, Gentian Diagnostics ASA, Ultimovacs ASA and BerGenBio ASA.
The bottom 10 Vaccines companies in Norway by Capital Expenditure are BerGenBio ASA, Ultimovacs ASA, Gentian Diagnostics ASA, Photocure ASA and Nykode Therapeutics AS.